Balanced news tone
News Sentiment
LFST sentiment intelligence
Lifestance Health Group Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
85/100 classification confidence.
directly relevant articles
high-authority source matches
-5.0% over one week, +25.9% over four weeks, trend active, and materially above fair value.
Behavioral Patterns of LFST and Institutional Flows
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Behavioral Patterns of LFST and Institutional Flows
This article analyzes the behavioral patterns and institutional flows for Lifestance Health Group Inc. (NASDAQ: LFST), identifying a near-term neutral sentiment amidst mid and long-term strength. It presents AI-generated trading strategies including position trading, momentum bre
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 15 Jul 2026 13:14
- Source
- Stock Traders Daily
LifeStance Health Group (NASDAQ:LFST) Surges with Perfect Technical Setup and Explosive High-Growth Fundamentals
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 Jul 2026 08:20
- Source
- ChartMill
LifeStance Health (LFST) director receives 45,495-share stock award
LifeStance Health Group, Inc. director Kenneth A. Burdick was awarded 45,495 shares of common stock at $0.0000 per share, an equity grant that includes restricted stock units. Following this transaction, Burdick directly holds 3,470,810 shares and indirectly holds 46,511 shares t
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 22:15
- Source
- Stock Titan
LFST Maintains by Barclays -- Price Target Raised to $13.00
Barclays has maintained its "Overweight" rating on LifeStance Health Group (LFST), increasing the price target to $13.00, signaling confidence in the company's growth within the mental healthcare sector. Despite this positive analyst sentiment, GuruFocus indicates that LFST is cu
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 14 Jul 2026 14:15
- Source
- GuruFocus
$3 million class action settlement ends class action lawsuit over LifeStance Health pixel tracking allegations
LifeStance Health Group has agreed to a $3,027,874.44 class action settlement over allegations it used pixel tracking technologies to collect and disclose patient information without authorization. Patients who booked sessions via lifestance.com between March 2020 and April 2023,
- Tone
- Negative 29/100
- Event
- Regulatory and legal
- Published
- 13 Jul 2026 09:46
- Source
- Claim Depot
LifeStance Deadline Alert
Faruqi & Faruqi, LLP is investigating potential claims against LifeStance Health Group, Inc. (NASDAQ: LFST) and reminds investors of the October 11, 2022 deadline to seek lead plaintiff status in a federal securities class action lawsuit. The lawsuit alleges that LifeStance and i
- Tone
- Negative 17/100
- Event
- Regulatory and legal
- Published
- 13 Jul 2026 07:11
- Source
- TMX Newsfile
LifeStance Health Group (LFST) Refreshes Its Board As Investors Weigh A Fully Valued Story
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jul 2026 10:31
- Source
- simplywall.st
LifeStance Health (LFST) director Lori Goltermann files initial Form 3
LifeStance Health Group, Inc. director Lori Goltermann has filed an initial Form 3, which is a statement of beneficial ownership for new insiders. This filing establishes her status as a reporting person but does not report any share purchases, sales, or other transactions. The F
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 18:10
- Source
- Stock Titan
Are You Looking for a Top Momentum Pick? Why LifeStance Health Group (LFST) is a Great Choice
LifeStance Health Group (LFST) is highlighted as a top momentum pick by Zacks Equity Research. The company holds a Zacks Rank of #1 (Strong Buy) and a Momentum Style Score of B, indicating strong potential for outperformance. Positive price performance, including a 9.63% increase
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 08 Jul 2026 15:40
- Source
- Market source
LifeStance (LFST) director Sarah Personette receives 17,746-share RSU grant
LifeStance Health Group, Inc. director Sarah Personette was granted 17,746 restricted stock units (RSUs) at a price of $0.00 per share, increasing her direct holdings to 92,512 shares. This grant is a compensation-related award, not an open-market purchase. Each RSU represents a
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 06:09
- Source
- Stock Titan
[Form 4] LifeStance Health Group, Inc. Insider Trading Activity
Justice Thurman, a Director at LifeStance Health Group, Inc. (LFST), received an award of 35,492 restricted stock units (RSUs) on July 2, 2026, as reported in a Form 4 filing. This transaction, valued at $0.00 per share, represents a compensation-related grant rather than an open
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 05:40
- Source
- Stock Titan
LifeStance Health (LFST) director granted 17,746 RSUs, holdings rise to 89,174 shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 23:42
- Source
- Stock Titan
Form 4 Lifestance Health Group Inc For: 7 July By Investing.com
This article from Investing.com is a regulatory filing update (Form 4) for Lifestance Health Group Inc. dated July 7. It provides financial market data, including stock performance indicators for LFST, and displays various global indices, commodities, and bond prices. The main co
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 08 Jul 2026 00:40
- Source
- Investing.com Nigeria
LifeStance (NASDAQ: LFST) director receives 35,492 restricted stock units
LifeStance Health Group, Inc. director Lori Goltermann was awarded 35,492 restricted stock units (RSUs) on July 2, 2026, at a price of $0.00 per share. This compensation grant, reported via a Form 4 filing, increases her direct holdings to 35,492 shares, contingent upon fulfillin
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 23:40
- Source
- Stock Titan
LifeStance (LFST) director Justice Thurman files baseline Form 3 with no trades
LifeStance Health Group, Inc. director Justice Thurman has filed an initial Form 3 ownership report, which is a baseline SEC disclosure indicating his status as a reporting person. The filing does not show any buy, sell, or other insider transactions or derivative positions, mean
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 23:40
- Source
- Stock Titan
LFST 12-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages LifeStance Health Group (LFST) Investors with Losses to Contact Firm's Attorneys Before Oct. 11th Deadline in Securities Class Action
Hagens Berman is urging investors of LifeStance Health Group (LFST) who have experienced significant losses to contact their attorneys before the October 11, 2022 deadline for a securities class action lawsuit. The lawsuit alleges that LifeStance's IPO Registration Statement fail
- Tone
- Negative 19/100
- Event
- Regulatory and legal
- Published
- 06 Jul 2026 17:11
- Source
- TMX Newsfile
Lifestance Health Group stock hits 52-week high at $8.11
Lifestance Health Group Inc. (LFST) stock reached a 52-week high of $8.11, with shares trading at $8.14 and a market capitalization of $3.08 billion, reflecting a 33.58% 1-year total return. InvestingPro analysis suggests the stock is undervalued, offering additional upside. Rece
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 06 Jul 2026 09:40
- Source
- Investing.com
LifeStance Q1 2026 presentation: 21% revenue growth, guidance raised
LifeStance Health Group Inc. reported strong first-quarter 2026 results, exceeding market expectations with 21% year-over-year revenue growth and substantial margin expansion. The mental healthcare provider raised its full-year financial guidance for 2026, anticipating continued
- Tone
- Positive 90/100
- Event
- Earnings
- Published
- 04 Jul 2026 09:10
- Source
- Investing.com
Does LifeStance Health (LFST) Losing Russell Index Spots Recast Its Role in Investors’ Portfolios?
LifeStance Health Group (LFST) was removed from several Russell indices in late June 2026, which may impact how passive funds and benchmark-aware investors engage with the stock. While the company has shown positive fundamentals, including profitability and raised revenue guidanc
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 03 Jul 2026 04:10
- Source
- Simply Wall Street
LifeStance Health Stock 9-Day Winning Spree: Stock Climbs 33%
LifeStance Health (LFST) stock experienced a 9-day winning streak, resulting in a 33% increase and a market cap surge of $1.1 billion to $4.4 billion. Despite this rally, the article suggests the stock is "Unattractive" due to moderate operating performance, financial condition,
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 14:32
- Source
- Trefis
LifeStance (LFST) director-linked LLCs sell 894k shares at $10.13 average
Entities linked to LifeStance Health Group director Robert Bessler, specifically Shama LLC and Vitthal LLC, sold a total of 894,337 shares of LFST common stock on June 26, 2026, at a weighted average price of $10.13 per share. These open-market transactions, filed via a Form 4, o
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 01 Jul 2026 02:39
- Source
- Stock Titan
LifeStance Health Group, Inc.(NasdaqGS:LFST) dropped from Russell 2000 Defensive Index
LifeStance Health Group, Inc. (NasdaqGS:LFST) has been removed from the Russell 2000 Defensive Index, as well as several other Russell indices including the Russell 2000 Value Benchmark and Russell Small Cap Comp Value Benchmark. The company, which provides virtual and in-person
- Tone
- Negative 29/100
- Event
- Market update
- Published
- 29 Jun 2026 21:10
- Source
- www.marketscreener.com
LifeStance Health Group, Inc.(NasdaqGS:LFST) dropped from Russell 3000 Value Benchmark
LifeStance Health Group, Inc. (NasdaqGS: LFST) has been removed from the Russell 3000 Value Benchmark. This news follows a series of other announcements where the company was dropped from various Russell indices, including the Russell 2000 Defensive Index and Russell Small Cap Co
- Tone
- Negative 38/100
- Event
- Market update
- Published
- 29 Jun 2026 15:39
- Source
- www.marketscreener.com
LifeStance Health Group, Inc.(NasdaqGS:LFST) dropped from Russell 2000 Value Benchmark
LifeStance Health Group, Inc. (NasdaqGS:LFST) has been removed from the Russell 2000 Value Benchmark, according to an announcement on June 29, 2026. This is one of several recent index changes for the company, including being dropped from the Russell 2000 Defensive Index and Russ
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 29 Jun 2026 11:33
- Source
- www.marketscreener.com
LifeStance Health Group, Inc.(NasdaqGS:LFST) dropped from Russell Small Cap Comp Value Benchmark
LifeStance Health Group, Inc. (NasdaqGS:LFST) has been removed from the Russell Small Cap Comp Value Benchmark, among other Russell indices, effective June 28-29, 2026. The company, which focuses on virtual and in-person mental healthcare, has experienced several such removals fr
- Tone
- Negative 29/100
- Event
- Market update
- Published
- 29 Jun 2026 03:09
- Source
- www.marketscreener.com
Lifestance Health Group stock hits 52-week high at $10.01
Lifestance Health Group Inc. (LFST) has reached a new 52-week high of $10.01, marking a 93.98% increase over the past year. The company recently completed a public offering of 35 million shares by existing stockholders and plans to repurchase 6 million shares from them. Goldman S
- Tone
- Positive 74/100
- Event
- Capital return
- Published
- 27 Jun 2026 13:10
- Source
- Investing.com
Price to earnings forward of LifeStance Health Group, Inc. – NASDAQ:LFST
This article provides pricing and financial information for LifeStance Health Group, Inc. (NASDAQ: LFST) on TradingView. It outlines how to access financial data, news, and technical analysis for the company. The content also details various features and services offered by Tradi
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Jun 2026 00:39
- Source
- TradingView
Lifestance Health Group stock hits 52-week high at $10.01 By Investing.com
Lifestance Health Group (LFST) has reached a new 52-week high of $10.01, demonstrating a 93.98% increase in its stock price over the past year. This surge follows significant events including an underwritten public offering by existing stockholders and an initiation of coverage b
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 26 Jun 2026 20:39
- Source
- Investing.com South Africa
Insiders sell LifeStance Health shares (NASDAQ: LFST) totaling $1.17M
LifeStance Health Group (NASDAQ: LFST) insiders reported sales of common stock totaling approximately $1.17 million across four transactions in April and May 2026. The sales were made by related holders, involving 5,101, 7,752, 62,147, and 75,000 shares, with proceeds ranging fro
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 20:11
- Source
- Stock Titan
Lifestance Health Group, Inc. Actuals & Estimates (NASDAQ:LFST)
This article provides an overview of LifeStance Health Group, Inc. (NASDAQ:LFST) stock, including its current price, historical performance, and analyst forecasts. It details financial actuals and estimates, revenue, net income, and upcoming earnings report dates, while also addr
- Tone
- Positive 73/100
- Event
- Earnings
- Published
- 26 Jun 2026 07:11
- Source
- TradingView